FrancophonIA/ELRC3.0 huggingface dataset:
English: If angioedema occurs, Sprimeo HCT should be promptly discontinued and appropriate therapy and monitoring provided until complete and sustained resolution of signs and symptoms has occurred.
Danish: Hvis angioødem opstår, skal Sprimeo HCT seponeres med det samme, og der skal gives relevant behandling og monitorering indtil komplet og vedvarende resolution af tegn og symptomer indtræffer.
English: Sprimeo HCT should be used with caution in patients with heart failure due to limited clinical efficacy and safety data.
Danish: Sprimeo HCT skal anvendes med forsigtighed til patienter med hjertesvigt pga. begrænsede kliniske effekt- og sikkerhedsdata.
English: Sprimeo HCT is used to treat high blood pressure.
Danish: Sprimeo HCT anvendes til behandling af for højt blodtryk.
English: There is no evidence that Sprimeo HCT would reduce or prevent diuretic-induced hyponatraemia.
Danish: Der er ingen dokumentation for, at Sprimeo HCT vil reducere eller forhindre diuretikainduceret hyponatriæmi.
English: Additional information on individual components Other adverse reactions previously reported with one of the individual components may occur with Sprimeo HCT even if not observed in clinical trials.
Danish: Yderligere oplysninger om individuelle komponenter Andre bivirkninger, der tidligere er blevet indberettet for en af de individuelle komponenter, kan forekomme med Sprimeo HCT, selvom de ikke er blevet observeret i kliniske forsøg.
English: Like all medicines, Sprimeo HCT can cause side effects, although not everybody gets them.
Danish: Sprimeo HCT kan som al anden medicin give bivirkninger, men ikke alle får bivirkninger.
English: Information on Sprimeo HCT interactions
Danish: Information om interaktioner med Sprimeo HCT
English: Important information about some of the ingredients of Sprimeo HCT Sprimeo HCT contains lactose (milk sugar).
Danish: Vigtig information om nogle af de øvrige indholdsstoffer i Sprimeo HCT Sprimeo HCT indeholder laktose (mælkesukker).
English: Always take Sprimeo HCT exactly as your doctor has told you.
Danish: Tag altid Sprimeo HCT nøjagtigt efter lægens anvisning.
English: Sprimeo HCT is not recommended for use in children and adolescents below age 18 due to a lack of data on safety and efficacy (see section 5.2).
Danish: Sprimeo HCT bør ikke anvendes til børn og unge under 18 år pga. manglende dokumentation for sikkerhed og virkning (se pkt.
English: Sprimeo HCT is unlikely to affect the ability to drive and use machines.
Danish: Det er usandsynligt, at Sprimeo HCT påvirker evnen til at føre motorkøretøj eller betjene maskiner.
English: General In the event of severe and persistent diarrhoea, Sprimeo HCT therapy should be stopped.
Danish: Generelt I tilfælde af alvorlig og vedvarende diarré bør behandling med Sprimeo HCT stoppes.
English: Sprimeo HCT should be discontinued if hypercalcaemia develops during treatment.
Danish: Sprimeo HCT skal seponeres, hvis der udvikles hyperkalcæmi under behandlingen.
English: In controlled clinical trials, the incidence of diarrhoea in Sprimeo HCT-treated patients was 1.3% compared to 1.4% for aliskirenor 1.9% for hydrochlorothiazide-treated patients.
Danish: I kontrollerede, kliniske forsøg var incidensen af diarré hos Sprimeo HCT-behandlede patienter 1,3 %, sammenlignet med 1,4 % for aliskiren- eller 1,9 % for hydrochlorthiazidbehandlede patienter.
English: Sprimeo HCT tablets contain two active substances, called aliskiren and hydrochlorothiazide.
Danish: Sprimeo HCT-tabletter indeholder to aktive stoffer, som kaldes aliskiren og hydrochlorthiazid.
English: Therefore, because of the risk of therapeutic failure, grapefruit juice should not be taken together with Sprimeo HCT.
Danish: På grund af risiko for terapeutisk svigt bør grapefrugtjuice ikke tages sammen med Sprimeo HCT.
English: Your doctor will normally advise you to stop taking Sprimeo HCT before you become pregnant or as soon as you know you are pregnant and will advise you to take another medicine instead of Sprimeo HCT.
Danish: Normalt vil din læge råde dig til at stoppe med at tage Sprimeo HCT, inden du bliver gravid, eller så snart du har konstateret, at du er gravid.
English: Following oral administration of Sprimeo HCT tablets, the median peak plasma concentration time is within 1 hour for aliskiren and 2.5 hours for hydrochlorothiazide.
Danish: Efter oral indgivelse af Sprimeo HCT-tabletter er tiden for middel peak-plasmakoncentrationen under 1 time for aliskiren og 2,5 timer for hydrochlorthiazid.
English: If Sprimeo HCT is used during breast-feeding, doses should be kept as low as possible.
Danish: Hvis Sprimeo HCT anvendes under amning, bør dosis holdes så lav som muligt.
English: You should not take Sprimeo HCT together with grapefruit juice.
Danish: Du må ikke tage Sprimeo HCT sammen med grapefrugtjuice.
English: The rate and extent of absorption of Sprimeo HCT are equivalent to the bioavailability of aliskiren and hydrochlorothiazide when administered as individual monotherapies.
Danish: Hastigheden og omfanget af absorptionen af Sprimeo HCT svarer til biotilgængeligheden for aliskiren og hydrochlorthiazid, når det indgives som individuelle monoterapier.
English: The recommended dose of Sprimeo HCT is one tablet per day.
Danish: Den anbefalede dosis af Sprimeo HCT er en tablet pr. dag.
English: Sprimeo HCT is not recommended during pregnancy, and must not be taken when more than 3 months pregnant, as it may cause serious harm to your baby if used after the third month of pregnancy.
Danish: Sprimeo HCT frarådes under graviditeten og må ikke tages, når du er mere end 3 måneder henne i graviditeten, fordi det kan forårsage alvorlig skade på dit barn, hvis det tages efter tredje graviditetsmåned.
English: If you take more Sprimeo HCT than you should If you have accidentally taken too many Sprimeo HCT tablets, talk to a doctor immediately.
Danish: Hvis du har taget for mange Sprimeo HCT-tabletter Hvis du er kommet til at tage for mange Sprimeo HCT-tabletter, skal du straks kontakte en læge.
English: Sprimeo HCT contains lactose.
Danish: Sprimeo HCT indeholder laktose.
English: If blood pressure remains uncontrolled after 2-4 weeks of therapy, the dose may be titrated up to a maximum of Sprimeo HCT 300 mg/25 mg daily.
Danish: Hvis blodtrykket ikke er under kontrol efter 2-4 ugers behandling kan dosis titreres op til en maksimal daglig dosis på 300 mg/25 mg Sprimeo HCT.
English: Sprimeo HCT combines two antihypertensive compounds to control blood pressure in patients with essential hypertension: Aliskiren belongs to the class of direct renin inhibitors and hydrochlorothiazide to the class of thiazide diuretics.
Danish: Sprimeo HCT kombinerer to antihypertensive komponenter til kontrol af blodtryk hos patienter med essentiel hypertension: Aliskiren tilhører klassen af direkte reninhæmmere og hydrochlorthiazid tilhører klassen af thiaziddiuretika.
English: If any of the above applies to you, do not take Sprimeo HCT and talk to your doctor.
Danish: Hvis noget af dette gælder for dig, skal du ikke tage Sprimeo HCT og fortælle det til lægen.
English: Sprimeo HCT is not recommended in early pregnancy, and must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if used at that stage (see Pregnancy section).
Danish: Sprimeo HCT frarådes i den tidlige periode af graviditeten og må ikke tages, hvis du er mere end 3 måneder henne i graviditeten, da det kan forårsage alvorlig skade på dit barn, hvis det tages på dette tidspunkt (se afsnittet om Graviditet).
English: If you forget to take Sprimeo HCT
Danish: Hvis du har glemt at tage Sprimeo HCT
English: Other antihypertensive agents: The antihypertensive effect of Sprimeo HCT may be increased with the concomitant use of other antihypertensive agents.
Danish: Andre antihypertensiva: Sprimeo HCT's antihypertensive virkning kan øges ved samtidig brug af andre antihypertensiva.
English: If photosensitivity reaction occurs during treatment with Sprimeo HCT, it is recommended to stop the treatment.
Danish: Hvis der opstår lysfølsomhedsreaktioner under behandlingen med Sprimeo HCT, anbefales det at seponere behandlingen.
English: Do not take Sprimeo HCT - if you are allergic (hypersensitive) to aliskiren or hydrochlorothiazide, to sulphonamide-derived medicines (medicines used to treat chest or urinary infections) or to any of the other ingredients of Sprimeo HCT.
Danish: Tag ikke Sprimeo HCT - hvis du er overfølsom (allergisk) over for aliskiren eller hydrochlorthiazid, sulfonamidafledt medicin (medicin, der anvendes til at behandle bryst- eller urinvejsinfektioner) eller et af de øvrige indholdsstoffer.
English: The adverse drug reactions previously reported with one of the individual components of Sprimeo HCT (aliskiren and hydrochlorothiazide) and listed in the respective paragraphs on the individual components may occur with Sprimeo HCT.
Danish: Bivirkningerne, der tidligere er indberettet for en af de individuelle komponenter i Sprimeo HCT (aliskiren og hydrochlorthiazid), og præsenteret i de respektive afsnit for de individuelle komponenter kan forekomme med Sprimeo HCT.
English: You may need to stop Sprimeo HCT.
Danish: Det kan være nødvendigt at stoppe behandlingen med Sprimeo HCT.
English: Take special care with Sprimeo HCT - if you have impaired kidney function, your doctor will carefully consider whether Sprimeo HCT
Danish: Vær ekstra forsigtig med at tage Sprimeo HCT - hvis du har nedsat nyrefunktion, vil din læge nøje overveje, om Sprimeo HCT er egnet til dig,
English: Sprimeo HCT has been shown to be effective as a once-a-day antihypertensive treatment in adult patients, regardless of gender, age, body mass index and ethnicity.
Danish: Sprimeo HCT har vist sig effektiv som antihypertensiv behandling en gang daglig til voksne patienter uanset køn, alder, BMI og etnicitet.
English: If pregnancy is detected during therapy, Sprimeo HCT should be discontinued as soon as possible.
Danish: Hvis der opstår graviditet under behandlingen, skal Sprimeo HCT seponeres så hurtigt som muligt.
English: The usual dose of Sprimeo HCT is one tablet a day.
Danish: Den sædvanlige dosis af Sprimeo HCT er én tablet daglig.
English: In hypertensive patients, once-daily administration of Sprimeo HCT provided dose-dependent reductions in both systolic and diastolic blood pressure that were maintained over the entire 24-hour dose interval.
Danish: Hos hypertensive patienter gav administration af Sprimeo HCT én gang dagligt dosis-afhængige reduktioner i både systolisk og diastolisk blodtryk, som blev vedligeholdt i hele 24-timers dosisintervallet.
English: Sprimeo HCT is contraindicated in patients with hypercalcaemia and should only be used after correction of any preexisting hypercalcaemia.
Danish: Sprimeo HCT er kontraindiceret til patienter med hyperkalcæmi og bør kun anvendes efter korrektion af præeksisterende hyperkalcæmi.
English: You should take Sprimeo HCT with a light meal once a day, preferably at the same time each day.
Danish: Du skal tage Sprimeo HCT sammen med et let måltid mad én gang om dagen, fortrinsvis på samme tidspunkt hver dag.
English: Medicinal products affected by serum potassium disturbances: Periodic monitoring of serum potassium is recommended when Sprimeo HCT is administered with medicinal products affected by serum potassium disturbances (e.g. digitalis glycosides, antiarrhythmics).
Danish: Lægemidler, der påvirkes af serumkaliumforstyrrelser: Regelmæssig overvågning af serumkalium anbefales, når Sprimeo HCT administreres sammen med lægemidler, der påvirkes af serumkaliumforstyrrelser (f.eks. digitalis glykosider, antiarytmika).
English: Grapefruit juice should not be taken together with Sprimeo HCT.
Danish: Grapefrugtjuice må ikke tages sammen med Sprimeo HCT.
English: Sprimeo HCT should be taken with a light meal once a day, preferably at the same time each day.
Danish: Sprimeo HCT bør tages sammen med et let måltid mad én gang dagligt, fortrinsvis på samme tidspunkt hver dag.
English: When Sprimeo HCT is used in patients with renal impairment, periodic monitoring of serum electrolytes including potassium, creatinine and uric acid serum levels is recommended.
Danish: Når Sprimeo HCT anvendes hos patienter med nedsat nyrefunktion, anbefales regelmæssig monitorering af serumelektrolytter herunder kalium, samt serum-kreatinin og serum-urinsyre.
English: In another clinical trial, the efficacy and safety of Sprimeo HCT were also assessed in 489 obese hypertensive patients who did not respond to hydrochlorothiazide 25 mg (baseline systolic/diastolic blood pressure 149.4/96.8 mmHg).
Danish: I et andet klinisk forsøg blev Sprimeo HCT's virkning og sikkerhed ligeledes vurderet i 489 overvægtige, hypertensive patienter, der ikke responderede på hydrochlorthiazid 25 mg (baseline systolisk/diastolisk blodtryk 149,4/96,8 mmHg).
English: Sprimeo HCT is indicated in patients whose blood pressure is not adequately controlled on aliskiren or hydrochlorothiazide used alone.
Danish: Sprimeo HCT er indiceret til patienter, hvis blodtryk ikke er tilstrækkeligt behandlet med aliskiren eller hydrochlorthiazid anvendt alene.
English: The most common adverse drug reaction observed with Sprimeo HCT is diarrhoea.
Danish: Den mest almindelige bivirkning set for Sprimeo HCT er diarré.
English: Sprimeo HCT was studied in a placebo-controlled trial including 2,762 hypertensive patients with diastolic blood pressure ≥ 95 mmHg and < 110 mmHg (mean baseline blood pressure of 153.6/99.2 mmHg).
Danish: Sprimeo HCT blev undersøgt i et placebokontrolleret forsøg, som inkluderede 2.762 hypertensive patienter med diastolisk blodtryk ≥ 95 mmHg og < 110 mmHg (middel baselineblodtryk på 153,6/99,2 mmHg).
English: In case severe or rapid hyponatraemia develops during Sprimeo HCT therapy, the treatment should be discontinued until normalisation of natraemia.
Danish: Hvis svær eller pludselig hyponatriæmi opstår under behandling med Sprimeo HCT, bør behandlingen seponeres, indtil natriumbalancen er normaliseret.
English: No specific clinical studies have been performed with this combination, therefore Sprimeo HCT should not be used during the first trimester of pregnancy or in women planning to become pregnant and is contraindicated during the second and third trimesters (see section 4.3).
Danish: Der er ikke udført nogen specifikke kliniske undersøgelser med denne kombination, og derfor bør Sprimeo HCT ikke anvendes i 1. trimester af graviditeten eller af kvinder, som planlægger at blive gravide.
English: There is no experience regarding the administration of Sprimeo HCT in patients who have recently undergone kidney transplantation.
Danish: Der er ingen erfaring med brug af Sprimeo HCT til patienter, der for nylig har fået foretaget en nyretransplantation.
English: Due to the hydrochlorothiazide component, Sprimeo HCT is contraindicated in symptomatic hyperuricaemia (see section 4.3).
Danish: På grund af indholdet af hydrochlorthiazid er Sprimeo HCT kontraindiceret ved symptomatisk hyperurikæmi (se pkt.
English: No information is available on the treatment of overdose with Sprimeo HCT.
Danish: Der er ikke rapporteret om tilfælde af overdosering med Sprimeo HCT.
English: If hypokalaemia develops during hydrochlorothiazide therapy Sprimeo HCT should be discontinued until stable correction of the potassium balance.
Danish: Hvis hypokaliæmi opstår under behandling med hydrochlorthiazid, bør Sprimeo HCT seponeres, indtil kaliumbalancen er genoprettet og stabil.
English: In this difficult-to-treat population, Sprimeo HCT provided a blood pressure reduction (systolic/diastolic) of 15.8/11.9 mmHg compared to 15.4/11.3 mmHg for irbesartan/hydrochlorothiazide, 13.6/10.3 mmHg for amlodipine/hydrochlorothiazide and 8.6/7.9 mmHg for hydrochlorothiazide monotherapy, with similar safety to hydrochlorothiazide monotherapy.
Danish: I denne population, der er svær at behandle, gav Sprimeo HCT en blodtryksreduktion (systolisk/diastolisk) på 15,8/11,9 mmHg sammenlignet med 15,4/11,3 mmHg for irbesartan/hydrochlorthiazid, 13,6/10,3 mmHg for amlodipin/hydrochlorthiazid og 8,6/7,9 mmHg for hydrochlorthiazid monoterapi med samme sikkerhedsprofil som for hydrochlorthiazid monoterapi.
English: Treatment with Sprimeo HCT should only start after correction of hypokalaemia and any coexisting hypomagnesaemia.
Danish: Behandling med Sprimeo HCT bør kun påbegyndes efter korrektion af hypokaliæmi og eventuel samtidig forekommende hypomagnesiæmi.
English: Sprimeo HCT is indicated as substitution therapy in patients adequately controlled with aliskiren and hydrochlorothiazide, given concurrently, at the same dose level as in the combination.
Danish: Sprimeo HCT er indiceret som erstatningsterapi hos patienter, hvis blodtryk er tilstrækkeligt behandlet med aliskiren og hydrochlorthiazid, givet samtidigt, på samme dosisniveau som i kombinationen.
English: or an “angiotensin 2 receptor blocker” such as valsartan, telmisartan, irbesartan etc. - if you are on a low-salt diet. - if you have signs and symptoms such as abnormal thirst, dry mouth, general weakness, drowsiness, muscle pain or cramps, nausea, vomiting, or an abnormally fast heart beat which may indicate an excessive effect of hydrochlorothiazide (contained in Sprimeo HCT).
Danish: eller en ”angiotensin-II receptorblokker”, som fx valsartan, telmisartan, irbesartan osv; - hvis du er på en diæt med lavt saltindhold; - hvis der er tegn og symptomer såsom unormal tørst, tør mund, generel svaghed, sløvhed, muskelsmerte eller kramper, kvalme, opkastning eller unormalt hurtige hjerteslag, som kan tyde på en overdreven virkning af hydrochlorthiazid (et af de aktive stoffer i Sprimeo HCT); - hvis du oplever hudreaktioner, som fx udslæt efter at have været i solen; - hvis du oplever nedsat syn eller øjensmerter.
English: Sprimeo HCT is available in packs containing 7, 14, 28, 30, 50, 56, 90,or 98 tablets.
Danish: Sprimeo HCT fås i pakninger med 7, 14, 28, 30, 50, 56, 90 eller 98 tabletter.
English: For convenience, patients receiving aliskiren and hydrochlorothiazide from separate tablets may be switched to a fixed combination tablet of Sprimeo HCT containing the same component doses.
Danish: Patienter, som får aliskiren og hydrochlorthiazid fra hver sin tablet, kan for nemhedens skyld skifte til Sprimeo HCT med den samme dosis af hver komponent.
English: Concomitant use of Sprimeo HCT with ARBs or ACEIs is contraindicated in patients with diabetes mellitus (see section 4.3).
Danish: Samtidig brug af Sprimeo HCT og ARB'er eller ACE-hæmmere er kontraindiceret hos patienter med diabetes mellitus (se pkt.
English: Similar food effect was observed for Sprimeo HCT as for the individual monotherapies.
Danish: Den påvirkning fra mad, der blev observeret for Sprimeo HCT, svarede til den virkning, som ses for de individuelle monoterapier.
English: Sprimeo HCT 150 mg/12.5 mg film-coated tablets Sprimeo HCT 150 mg/25 mg film-coated tablets Sprimeo HCT 300 mg/12.5 mg film-coated tablets Sprimeo HCT 300 mg/25 mg film-coated tablets Aliskiren/hydrochlorothiazide
Danish: Sprimeo HCT 150 mg/12,5 mg filmovertrukne tabletter Sprimeo HCT 150 mg/25 mg filmovertrukne tabletter Sprimeo HCT 300 mg/12,5 mg filmovertrukne tabletter Sprimeo HCT 300 mg/25 mg filmovertrukne tabletter Aliskiren/hydrochlorthiazid
English: In this study, Sprimeo HCT in doses from 150 mg/12.5 mg to 300 mg/25 mg produced dose-dependent blood pressure reductions (systolic/diastolic) from 17.6/11.9 mmHg to 21.2/14.3 mmHg, respectively, compared to 7.5/6.9 mmHg with placebo.
Danish: I dette studie viste Sprimeo HCT i doser fra 150 mg/12,5 mg til 300 mg/25 mg dosisafhængige blodtryksreduktioner (systolisk/diastolisk) fra henholdsvis 17,6/11,9 mmHg til 21,2/14,3 mmHg, sammenlignet med 7,5/6,9 mmHg for placebo.
English: When administered in hypertensive patients with markedly elevated blood pressure (systolic blood pressure ≥ 160 mmHg and/or diastolic blood pressure ≥ 100 mmHg), Sprimeo HCT in doses from 150 mg/12.5 mg to 300 mg/25 mg administered without up-titration from monotherapy demonstrated significantly greater systolic/diastolic blood pressure control rates (< 140/90 mmHg) as compared to the respective monotherapies.
Danish: Ved administration til hypertensive patienter med markant forhøjet blodtryk (systolisk blodtryk ≥ 160 mmHg og/eller diastolisk blodtryk ≥ 100 mmHg), viste Sprimeo HCT i doser fra 150 mg/12,5 mg til 300 mg/25 mg, der blev givet uden optitrering fra monoterapi, signifikant større og hurtigere systolisk/diastolisk blodtrykskontrol (< 140/90 mmHg) sammenlignet med de respektive monoterapier.
English: There is no clinical experience with Sprimeo HCT in patients with hepatic impairment.
Danish: Der er ingen klinisk erfaring med Sprimeo HCT til patienter med nedsat leverfunktion.
English: No initial dose adjustment of Sprimeo HCT is required in elderly patients.
Danish: Der kræves ingen justering af initialdosen hos ældre patienter.
English: In this population, Sprimeo HCT 150 mg/12.5 mg to 300 mg/25 mg provided dose-dependent systolic/diastolic blood pressure reduction from 20.6/12.4 mmHg to 24.8/14.5 mmHg, which were significantly superior to the respective monotherapies.
Danish: I denne population gav Sprimeo HCT 150 mg/12,5 mg til 300 mg/25 mg en dosisafhængig systolisk/diastolisk blodtryksreduktion fra 20,6/12,4 mmHg til 24,8/14,5 mmHg, som var signifikant overlegen i forhold til de respektive monoterapier.
English: No data are available on patients with severe hepatic impairment treated by Sprimeo HCT.
Danish: Der ingen tilgængelige data om patienter med stærkt nedsat leverfunktion og behandling med Sprimeo HCT.
English: Treatment with Sprimeo HCT had an overall incidence of adverse experiences at doses up to 300 mg/25 mg similar to placebo.
Danish: Hyppigheden af bivirkninger ved behandling med Sprimeo HCT i doser op til 300 mg/25 mg svarede overordnet til placebos.
English: Sprimeo HCT should be used only after correction of any pre-existing sodium and/or volume depletion.
Danish: Sprimeo HCT bør kun bruges efter korrektion af eventuel eksisterende væske- eller natriummangel.
English: No data are available for the use of Sprimeo HCT in patients with severe hepatic impairment.
Danish: Der er ingen tilgængelige data fra brug af Sprimeo HCT hos patienter med stærkt nedsat leverfunktion.
English: Sprimeo HCT is contraindicated in patients with anuria or severe renal impairment (GFR < 30 ml/min/1.73 m2) and the concomitant use of Sprimeo HCT with ARBs or ACEIs is contraindicated in patients with renal impairment (GFR < 60 ml/min/1.73 m
Danish: Sprimeo HCT er kontraindiceret hos patienter med anuri eller stærkt nedsat nyrefunktion (GFR < 30 ml/min/1,73 m2) og samtidig brug af Sprimeo HCT og ARB'er eller ACE-hæmmere er kontraindiceret hos patienter med nedsat nyrefunktion (GFR < 60 ml/min./1,73 m2) (se pkt.
English: Consequently, no initial dose adjustment of Sprimeo HCT is required in patients with mild to moderate hepatic impairment.
Danish: Justering af initialdosen af Sprimeo HCT er derfor ikke nødvendig hos patienter med let til moderat nedsat leverfunktion.
English: Photosensitivity reactions
Danish: (overfølsomhedsreaktioner)
English: Renal artery stenosis and renovascular hypertension No controlled clinical data are available on the use of Sprimeo HCT in patients with unilateral or bilateral renal artery stenosis, or stenosis to a solitary kidney.
Danish: Der er ingen tilgængelige kontrollerede kliniske data om brug af Sprimeo HCT til patienter med unilateral eller bilateral nyrearteriestenose eller brug af Sprimeo HCT hos patienter med en nyre.
English: Sprimeo HCT contains wheat starch.
Danish: Sprimeo HCT indeholder hvedestivelse.
English: Due to the hydrochlorothiazide component, Sprimeo HCT is contraindicated for use in patients with anuria and in patients with severe renal impairment (glomerular filtration rate (GFR) < 30 ml/min/1.73 m2).
Danish: På grund af indholdet af hydrochlorthiazid er Sprimeo HCT kontraindiceret til patienter med anuri og til patienter med stærkt nedsat nyrefunktion (glomerulær filtrationshastighed (GFR) < 30 ml/min/1,73 m2).
English: What Sprimeo HCT is and what it is used for Before you take Sprimeo HCT How to take Sprimeo HCT Possible side effects
Danish: Det skal du vide, før du begynder at tage Sprimeo HCT Sådan skal du tage Sprimeo HCT Bivirkninger